DAFTAR PUSTAKA
1. Goodman NF, et al. American Association of Clinical Endocrinnologists Medical Guidelines For Clinical Practice For The Diagnosis And Treatment of Menopause. Endocr Pract. 2011;17(Suppl 6).
2. Fischl F. Hormone replacement therapy through the ages New cognition and therapy concepts. Krause & Pachernegg GmbH.
3. Milsom I. Menopause-related symptoms and their treatment. European Board and College of Obstetrics and Gynecology, 2012.
4. Greendale G.A, et al. Menopause-associated Symptoms and Cognitive Performance: Results From the Study of Women’s Health Across the Nation. Am J Epidemiol 2010;171:1214–1224.
5. O’Reagan C, et al. Mental Health And Cognitive Function. The Irish Longitudinal Study on Aging, 2012.
6. Henderson V. W. Cognitive Changes After Menopause: Influence of Estrogen. Clin Obstet Gynecol. 2008 September ; 51(3): 618–626.
7. Victorian Department of Health. The Assessment of Older People with dementia and depression of Culturally and Linguistically Diverse Backgrounds: A review of current practice and the development of guidelines for Victorian Aged Care Assessment Services. undertaken by the National Ageing Research Institute, 2011.
8. Jorm A. The informant questionnaire on cognitive decline in the elderly (IQCODE): a review. International Psychogeriatrics (2004), 16:3, 1–19 C _ 2004 International Psychogeriatric Association.
9. Sutanto L, Sutanto D.B. Menopause wanita dan gizi. FKUI, Jakarta. 2005.
10. Shimp LA, Smith MA. 20 Common Problems in Women,s Health Care International Edition 2000.Singapore : McGraw – Hill Book & Co. 2000.
11. Kaunitz AM. Oral contraceptive use in menopause. American Journal Obstetry & Gynecology 2001; 185: S32-7.
13. Nochtigall LE. The symptoms of perimenopause. Clinical Obstetry & Gynecology 1998;41:921-27.
14. Zollner YF, Acquadro C, Schaefer M. Literature review of instruments to assess health-related quality of life during and after menopause. Quality of Life Research. 2005;14:309–27.
15. Heinemann LAJ, Dominh T, Strelow F, Gerbsh S, Schnitker J, Schneider HPG. The Menopause Rating Scale (MRS) as outcome measure for hormone treatment? A validation study. Health Quality of Life Outcomes 2004;2:67.
16. Finkel T, Holbrook NJ. Oxidants, oxidative stres and the biology of ageing. Nature Journal Medicine. 2000:408.
17. Aebi H (1984).”Catalase in vitro”. Methodology. Enzymology. . Methods in Enzymology 105:121-126.
18. Castanho VS, Nakamura RT, Pinto-Neto AM, De Faria EC. Post menopausal Therapy Reduces Catalase Activity and Attenuates Risk. Original article. Arab Brasil Cardiology. 2012; vol.99 (5):1008-1014.
19. Kumar V, Abbas AK, Fausto N, Aster JC, Hauth JC. Robbins and Cotran Pathologic Basic of Desease.Eight edition.Cellular adaptation, Cell injury and Cell Death, 1 : 16 -18.
20. Soewondo P. Menopause, andropause dan somatopause perubahan hormonal pada proses menua. Dalam : Sudoyo AW, Setiohadi B, Alwi I, Simadibrata M, Setiati S, Editor. Buku ajar ilmu penyakit dalam. Edisi V. Jakarta : Pusat Penerbitan Ilmu Penyakit Dalam Fakultas Kedokteran Indonesia; 2009. 2078-82.
21. Jung MH and Kim HY. Effects of estogen on cognition and dementia. Journal of women’s medicine 2010.
22. Braverman et al. cognitive decline of aging: important neuroendocrinological predictors of early cognitive decline in a clinical setting. PATH Medical New York 2013.
23. Connections. Cognition & memory: how hormones influence our minds. Connections 2014.
24. Shughrue PJ, Lane MV, Merchenthaler I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J Comp Neurol 1997;388:507-25.
26. Kugaya A, Epperson CN, Zoghbi S, et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry 2003; 160:1522-4.
27. Shaywitz SE, Shaywitz BA, Pugh KR, et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999;281: 1197-202.
28. Cowley, S.M., Hoare, S., Mosselman, S., Parker, M.G., 1997. Estrogen receptors alpha and beta form heterodimers on DNA. J. Biol. Chem. 272, 19858–19862.
29. Daniel JM, et al. Long-term consequences of estrogens administered in midlife on female cognitive aging. Hormone and behavior 74 (2015) 77-85.
30. Gaub, M.P., Bellard, M., Scheuer, I., Chambon, P., Sassone-Corsi, P., 1990. Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 63, 1267–1276.
31. Barrett LF, TugadeMM,EngleRW (2004) Individual differences in working memory capacity and dual-process theories of the mind. Psychol Bull 130:553–573.
32. Cai JX, Arnsten AF (1997) Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 283:183–189.
33. Xiao L, Becker JB (1994) Quantitative microdialysis determination of extracellular striatal dopamine concentration in male and female rats: effects of estrous cycle and gonadectomy. Neurosci Lett 180:155– 158.
34. Pasqualini C, Olivier V, Guibert B, Frain O, Leviel V (1995) Acute stimulatory effect of estradiol on striatal dopamine synthesis. J Neurochem 65:1651–1657.
35. Becker JB (1990) Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysis. Neurosci Lett 118:169 –171.
36. Rannevik, G., Jeppsson, S., Johnell, O., Bjerre, B., Laurell-Borulf, Y., Svanberg, L., 2008. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 61, 67–77.
38. Chlebowski, R.T., Hendrix, S.L., Langer, R.D., Stefanick, M.L., Gass, M., Lane, D., Rodabough, R.J., Gilligan, M.A., Cyr, M.G., Thomson, C.A., Khandekar, J., Petrovitch, H., McTiernan, A., 2003. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomized trial. JAMA 289, 3243–3253.
39. Craig, M.C., Maki, P.M., Murphy, D.G., 2005. The Women's Health Initiative Memory Study: findings and implications for treatment. Lancet Neurol. 4, 190–194.
40. Luine V.N.
Estradiol and cognitive function: Past, present and future.
Hormones and Behavior 66 (2014) 602–618.41. Daniel JM, et al. Long-term consequences of estrogens administered in midlife on female cognitive aging. Hormone and behavior 74 (2015) 77-85.
42. Boulware, M.I., Kent, B.A., Frick, K.M., 2012. The impact of age-related ovarian hormone loss on cognitive and neural function. Curr. Top. Behav. Neurosci. 10, 165–184. Bov.
43. Luine, V.N., 2014. Estradiol and cognitive function: past, present and future. Horm. Behav. 66, 602–618.
44. Bimonte-Nelson, H.A., Acosta, J.I., Talboom, J.S., 2010. Neuroscientists as cartographers: mapping the crossroads of gonadal hormones,memory and age using animalmodels. Molecules 15, 6050– 6105.
45. Ditkoff EC, Crary WG, Cristo M, Lobo RA 1991 Estrogen im proves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78:991–995.
46. Sherwin BB, Gelfand MM. 1985 Sex steroids and affect in the surgical
menopause: a double-blind, cross-over study.
Psychoneuroendocrinology 10:325–335.
47. Sherwin BB 1988. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 14:177–187.
48. Sherwin BB 1991. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72:336–343.
50. Preciados M et al. Estrogenic endocine disrupting chemicals inflencing NRF1 regulated gene networks in the development of complex human brain disease. International jouranl of molecular sciences 2016.
51. Egan, K.R.; Gleason, C.E. Longer duration of hormonal contraceptive use predicts better cognitive outcomes later in life. J. Women’s Health 2012, 21, 1259–1266.
52. Griksiene, R.; Ruksenas, O. Effects of hormonal contraceptives on mental rotation and verbal fluency. Psychoneuroendocrinology 2011, 36, 1239–1248.
53. Warren, A.M.; Gurvich, C.; Worsley, R.; Kulkarni, J. A systematic review of the impact of oral contraceptives on cognition. Contraception 2014, 90, 111–116.
54. Brinton, R.D., 2005. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann. N. Y. Acad. Sci. 1052, 57–74.
55. Suzuki, S., Brown, C.M., Dela Cruz, C.D., Yang, E., Bridwell, D.A.,Wise, P.M., 2007. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc. Natl. Acad. Sci. U. S. A. 104, 6013–6018.
56. Maki, P.M., 2013. Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies. Menopause 20, 695– 709.
57. Henderson V. Cognitive symptoms and disorders in the midlife woman. The female patient 2011.
58. Hogervorst E, De Jager C, Budge M, Smith AD. Serum levels of estradiol and testosterone and performance in different cognitive
domains in healthy elderly men and women.
Psychoneuroendocrinology 2004;29:405-21.
59. Maki PM, Resnick SM. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 2000;21:373-83.
60. Phillips SM, Sherwin BB. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992;17:485-95.
62. Duka T, Tasker R, McGowan JF 2000 The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 149:129–139.
63. Ryan J et al. impact of a premature menopause on cognitive function in later life. Royal college of obstetricians and gynaecologists 2014.
64. Siregar MF et al. The differences of catalase enzyme level between menopause and reproductive women. Giorn. It. Ost. Gin. Vol. XXXVII - n. 6.
65. Rocca WA, Bower JH, Maraganore DM, Ahlskog JE, Grossardt BR, de Andrade M, et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007;69:1074–83.
66. Whalley L, et al. Age at natural menopause and cognition. Elsevier 2004.
67. Greendale G. Perimenopause and cognition. Obstet Gynecol Clin North Am. 2011 September ; 38(3): 519–535.
68. Gordon, RM, 2011. Definitions of MMPI/MMPI-2 scales: Scales of Validity and Bias. The Institute advanced & Psychological Training.Available at:http://www.mmpi-info.com/mmpi-2/mmpidict1.html.Cited on May 25th , 2011 at 11.00 PM.
69. Victorian Department of Health. The Assessment of Older People with dementia and depression of Culturally and Linguistically Diverse Backgrounds: A review of current practice and the development of guidelines for Victorian Aged Care Assessment Services. undertaken by the National Ageing Research Institute, 2011.
70. Jorm A. The informant questionnaire on cognitive decline in the elderly (IQCODE): a review. International Psychogeriatrics (2004), 16:3, 1–19 C _ 2004 International Psychogeriatric Association.
71. Lee KL, Shahar S, Rajab NF. Serum folate concentration, cognitive impairment, and DNA damage among elderly individuals in Malaysia. Nutrition Research 29 (2009) 327–334.
72. Dahlan MS. Besar sampel. Jakarta: Salemba Medika, 2009
73. Fallahzadeh H. Quality of life after the menopause in Iran. Quality of Life Research 2010;19:813-819.
Available from:
